- Home
- SCPH vs MAV Comparison
SCPH vs MAV Comparison
Compare SCPH & MAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCPH
- MAV
- Stock Information
- Founded
- SCPH 2013
- MAV 2003
- Country
- SCPH United States
- MAV United States
- Employees
- SCPH N/A
- MAV N/A
- Industry
- SCPH Biotechnology: Pharmaceutical Preparations
- MAV Finance Companies
- Sector
- SCPH Health Care
- MAV Finance
- Exchange
- SCPH Nasdaq
- MAV Nasdaq
- Market Cap
- SCPH 179.6M
- MAV 202.6M
- IPO Year
- SCPH 2017
- MAV N/A
- Fundamental
- Price
- SCPH $3.24
- MAV $8.56
- Analyst Decision
- SCPH Strong Buy
- MAV
- Analyst Count
- SCPH 2
- MAV 0
- Target Price
- SCPH $15.00
- MAV N/A
- AVG Volume (30 Days)
- SCPH 412.0K
- MAV 66.2K
- Earning Date
- SCPH 03-12-2025
- MAV 01-01-0001
- Dividend Yield
- SCPH N/A
- MAV 4.30%
- EPS Growth
- SCPH N/A
- MAV N/A
- EPS
- SCPH N/A
- MAV N/A
- Revenue
- SCPH $30,278,000.00
- MAV N/A
- Revenue This Year
- SCPH $172.64
- MAV N/A
- Revenue Next Year
- SCPH $131.43
- MAV N/A
- P/E Ratio
- SCPH N/A
- MAV N/A
- Revenue Growth
- SCPH 303.87
- MAV N/A
- 52 Week Low
- SCPH $3.08
- MAV $6.37
- 52 Week High
- SCPH $6.54
- MAV $8.34
- Technical
- Relative Strength Index (RSI)
- SCPH 40.08
- MAV 50.88
- Support Level
- SCPH $3.27
- MAV $8.43
- Resistance Level
- SCPH $3.59
- MAV $8.55
- Average True Range (ATR)
- SCPH 0.20
- MAV 0.08
- MACD
- SCPH -0.01
- MAV 0.01
- Stochastic Oscillator
- SCPH 15.00
- MAV 87.50
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.
About MAV Pioneer Municipal High Income Advantage Fund Inc.
Pioneer Muni High Income Advantage Tr is a closed-end fund designed to pursue high current income exempt from regular federal income tax and as a secondary objective to seek capital appreciation. It predominantly invests in debt securities and other obligations issued by or on behalf of states, territories, and possessions of the United States and the District of Columbia and their political subdivisions, agencies, and instrumentalities, the interest on which is exempt from regular federal income tax.